Science Explorer Back to mapMap
Discussion
Researcher · Seattle Children's Hospital · United States

Erin R. Rudzinski

Erin R. Rudzinski publishes mostly in Pulmonary and Respiratory Medicine, Molecular Biology and Oncology, on topics such as Sarcoma Diagnosis and Treatment, Tumors and Oncological Cases and Neuroblastoma Research and Treatments.

ORCID 0000-0002-7591-956X OpenAlex
World rank
#131,276
of 7,710,434 ranked researchers
Rank in United States
#49,849
of 1,627,098
Works
243
Citations
9.3k
Citations per work
38.1
h-index
41
i10-index 82Top 4.2% in Pulmonary and Respiratory Medicine
Erin R. Rudzinski

What does Erin R. Rudzinski research?

Erin R. Rudzinski's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 138 works · 56.9% of their workMedicine: 138 works · 56.9% of their workPulmonary and Respiratory Medicine: 64 works · 26.5% of their workOncology: 21 works · 8.5% of their workNeurology: 19 works · 7.8% of their workSurgery: 18 works · 7.4% of their workRheumatology: 16 works · 6.7% of their workEverything else: 84 works · 34.6% of their workLife Sciences: 21 works · 8.5% of their workBiochemistry, Genetics and Molecular Biology: 21 works · 8.5% of their workMolecular Biology: 21 works · 8.5% of their workTHEIR WORKErin R. Rudzinski243works
Life Sciences8%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine13856.9%
  2. Everything else8434.6%
    1. Biochemistry, Genetics and Molecular Biology218.5%
  1. 1Pulmonary and Respiratory Medicine26% of their works
  2. 2Molecular Biology8% of their works
  3. 3Oncology8% of their works
  4. 4Neurology8% of their works
  5. 5Surgery7% of their works
  6. 6Rheumatology7% of their works

Research topics

Which keywords describe Erin R. Rudzinski's research?

The keywords of their largest research topics: Prognostic Factors, Osteosarcoma, Soft Tissue Sarcoma, Genetic Mutations, Immunotherapy, Granular Cell Tumor, Immunohistochemical Assessment and ALK.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Prognostic Factors952 topics
  2. Osteosarcoma861 topic
  3. Soft Tissue Sarcoma861 topic
  4. Genetic Mutations312 topics
  5. Immunotherapy292 topics
  6. Granular Cell Tumor241 topic
  7. Immunohistochemical Assessment241 topic
  8. ALK201 topic
  9. Neuroblastoma201 topic
  10. EGFR Mutations141 topic
  11. Targeted Therapy141 topic
  12. Chondrosarcoma121 topic
  13. Chordoma121 topic
  14. Neurofibromatosis111 topic
  15. Tumor Suppressor111 topic
  16. CAR T Cells91 topic
  17. Chimeric Antigen Receptor91 topic
  18. Desmoid Tumor91 topic
  19. Solitary Fibrous Tumor91 topic

Where does Erin R. Rudzinski work?

Erin R. Rudzinski's main affiliation in the publication record is Seattle Children's Hospital, United States.

How many publications and citations does Erin R. Rudzinski have?

OpenAlex counts 243 works and 9,258 citations for Erin R. Rudzinski, an h-index of 41, ranking #131,276 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Erin R. Rudzinski. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.